search  
 


Home

Who are we?

Why
register?


Signup for
registration


Online registration

Log in to register
your trial


Search a trial

NRT en CCMO

Contact

NEDERLANDS





MetaRegister
van CCT (UK)


ISRCTN-Register
van CCT (UK)


Effectiviteit van de Melodic Intonation Therapy (MIT).


- candidate number6336
- NTR NumberNTR1961
- ISRCTNISRCTN wordt niet meer aangevraagd.
- Date ISRCTN created
- date ISRCTN requested
- Date Registered NTR19-aug-2009
- Secondary IDs(I) MEC-2009-182, (II) 07.08.31-2007/0168 (I) METC Erasmus MC Rotterdam, (II) Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting
- Public TitleEffectiviteit van de Melodic Intonation Therapy (MIT).
- Scientific TitleThe efficacy of Melodic Intonation Therapy (MIT) in aphasia rehabilitation.
- ACRONYMMIT
- hypothesisMIT leads to improved verbal communication in aphasic patients with severe output disorders.
- Healt Condition(s) or Problem(s) studiedAphasia, Verbal apraxia
- Inclusion criteria1. Aphasia after LH stroke;
2. Time post onset: 2-3 months (post-acute group) or > 1 year (chronic group);
3. Native speaker of Dutch;
4. Candidate for MIT:
A. Nonfluent (< 50 words per minute);
B. Severe restriction of repetition (AAT subscore repetition <75 and AAT subtest repetition of sentences <11);
C. Articulation problems (AAT spontaneous speech score articulation <3);
D. Good to moderate auditory comprehension (functional comprehension >5 and AAT subtest auditory comprehension > 32).
5. Age: 18-80 years;
6. Right-handed.
- Exclusion criteria1. Severe hearing deficit;
2. Premorbid dementia;
3. Recent psychiatric history.
- mec approval receivedyes
- multicenter trialyes
- randomisedyes
- masking/blindingSingle
- controlActive
- groupParallel
- Type2 or more arms, randomized
- Studytypeintervention
- planned startdate 1-okt-2009
- planned closingdate1-apr-2011
- Target number of participants80
- InterventionsMelodic Intonation Therapy (MIT):
Language production therapy in which the melodic aspects of language (rythm, intonation) are used to train the production of sentences. MIT is given for 6 weeks, 5 hour per week.

Non-MIT (control condition in post-acute group):
Comprehension and production of written sentences. In the control condition, therapy is also given for 6 weeks, 5 hours per week.

No treatment (control condition in chronic group): No individual treatment for 6 weeks. Participation in group treatment (1 time per week) is allowed.
- Primary outcomeCIU's/minute on the Sabadel:
1. CIU (correct information units): Words in the patients' production that are adequate, comprehensible, relevant, and informative in relation to the target story;
2. In the Sabadel task, the examiner reads a story to the patient. The story is supported by pictures. The patient's task is to retell the story, while looking at the pictures.
- Secondary outcome1. Repetition of trained and untrained items;
2. AAT (interview, repetition, picture description);
3. ANELT.
- Timepoints1. T1 (before treatment):
Assessments: Sabadel, repetition of trained and untrained items, AAT, ANELT, PALPA 45 (word comprehension);
2. T2 (after 6 weeks of treatment):
Assessments: Sabadel, repetition of trained and untrained items, AAT, ANELT, PALPA 45 (word comprehension);
3. T3 (after 12 weeks):
Assessments: Sabadel, repetition of trained and untrained items, AAT, ANELT, PALPA 45 (word comprehension).
- Trial web siteN/A
- statusinclusion stopped: follow-up
- CONTACT FOR PUBLIC QUERIESDr. A.C. Meulen, van der
- CONTACT for SCIENTIFIC QUERIESDr. A.C. Meulen, van der
- Sponsor/Initiator Rijndam revalidatiecentrum Rotterdam, the Netherlands
- Funding
(Source(s) of Monetary or Material Support)
Stichting Rotterdams Kinderrevalidatie Fonds Adriaanstichting
- PublicationsN/A
- Brief summaryBackground:
Aphasic patients with limited verbal output often show beneficial effect of singing on language production. The MIT was devised to use this capacity in the treatment of aphasia. It uses the melodic aspects of language, such as rythm and intonation. Many case studies have reported spectacular results after MIT. At the moment, there is level III evidence for MIT, mainly for the chronic phase.
Aim:
Establish a higher level of evidence for MIT, both for the chronic phase and for the post-acute phase, when aphasia treatment is regularly provided. Further, it will be investigated whether the efficacy of MIT depends on patient characteristics, such as age, gender, location and seize of the lesion, and severity of the aphasia.
- Main changes (audit trail)
- RECORD19-aug-2009 - 5-apr-2013


  • Indien u gegevens wilt toevoegen of veranderen, kunt u een mail sturen naar nederlands@trialregister.nl